Mirum Pharmaceuticals, Inc. (MIRM)

Healthcare · Biotechnology · NASDAQ

Mirum Pharmaceuticals, Inc. (MIRM) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.93B and a free-cash-flow yield of 1.2%. Over the most recent reported fiscal year, revenue grew 54.7%.

Market cap	$5.93B
Trailing P/E	—
FCF yield	1.2%
Revenue growth (YoY)	+54.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live MIRM data on Nama Insights →